Nasdaq’s Sonnet to Merge With Rorschach, Form $888 Million Crypto Treasury Firm
Sonnet BioTherapeutics, a Nasdaq-listed clinical-stage biotechnology company, said it will merge with Rorschach I LLC in an all-stock…
Browsing Tag